The prevalence and clinical characteristics of MS in northern Japan

Journal of the Neurological Sciences

Volumn 211, Issue 1-2, 2003, Pages 49-53

  Houzen, Hideki ^a   Niino, Masaaki ^b   Kikuchi, Seiji ^b   Fukazawa, Toshiyuki ^c   Nogoshi, Shinji ^a   Matsumoto, Hiroyuki ^d   Tashiro, Kunio ^b  

^a Obihiro Kosei General Hospital   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Hokuyukai Neurology Hospital   (Japan)

^d SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

HLA; Japanese; MRI; Multiple sclerosis; Optic neuritis; Prevalence rate

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH SURVEY; HOSPITAL; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; SEX RATIO;

EID: 0038290645     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(03)00033-9     Document Type: Article

References (25)

1. Johnson R.T. The virology of demyelinating diseases. Ann. Neurol. 36(Suppl.):1994;S54-S60.
2. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol. Sci. 22:2001;117-139.
3. Okinaka S., Reese H.H., Katsuki S.et al. The prevalence of multiple sclerosis and other neurological diseases in Japan. Acta Neurol. Scand. 19:1966;68-76.
4. Kuroiwa Y., Shibasaki H., Ikeda M. Prevalence of multiple sclerosis and its north-to-south gradient in Japan. Neuroepidemiology. 2:1983;62-69.
5. Shibasaki H., Kuroda Y., Kuroiwa Y. Clinical studies of multiple sclerosis in Japan: classical multiple sclerosis and Devic's disease. J. Neurol. Sci. 23:1974;215-222.
6. Kuroiwa Y., Igata A., Itahara K., Koshijima S., Tsubaki T. Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1,084 cases. Neurology. 25:1975;845-851.
7. Shibasaki H., McDonald W.I., Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J. Neurol. Sci. 49:1981;253-271.
8. Shibasaki H., Kubo N., Nishitani H., Saida T., Ohno Y., Fukuyama Y. Nationwide survey of multiple sclerosis in Japan: reappraisal of clinical features. J. Trop. Geogr. Neurol. 2:1992;73-82.
9. Fukazawa T., Tashiro K., Hamada T.et al. Multiple sclerosis in Hokkaido, the northernmost island of Japan: prospective analyses of clinical features. Intern. Med. 31:1992;349-352.
10. Poser C.M., Paty D.W., Scheinberg L. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
11. Schoenberg B.S. Calculating confidence interval for rates and ratios. Neuroepidemiology. 2:1983;257-265.
12. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452.
13. Paty D.W., Noseworthy J.H., Ebers G.C. Diagnosis of multiple sclerosis. Paty D.W., Ebers G.C. Multiple Sclerosis. 1997;55-56 FA Davis, Philadelphia.
14. Yu Y.L., Woo E., Hawkins B.R., Ho H.C., Huang C.Y. Multiple sclerosis amongst Chinese in Hong Kong. Brain. 112:1989;1445-1467.
15. Lau K.K., Wong L.K., Li L.S., Chan Y.W., Li H.L., Wong V. Epidemiological study of multiple sclerosis in Hong Kong Chinese: questionnaire survey. Hong Kong Med. J. 8:2002;77-80.
16. Alter M., Okihiro M., Rowley W., Morris T. Multiple sclerosis among Orientals and Caucasians in Hawaii. Neurology. 21:1971;122-130.
17. Kurland L.T. The frequency and geographic distribution of multiple sclerosis as indicated by mortality statistics and morbidity survey in the United States and Canada. Am. J. Hyg. 55:1952;457-476.
18. Roth MP, Ballivet S, Descoins P, et al. Multiple sclerosis in Pyrenees-Atlantiques: a case-control study conducted in the southwest of France. In: Firnhaber W, Lauer K, editors. Multiple sclerosis in Europe: an epidemiological update. Darmstadt: Leuchtturm-Verlag/LTV Press; 1994. p. 177-8.
19. Kurtzke J.F. Geography in multiple sclerosis. J. Neurol. 215:1977;1-26.
20. Compston A. Genetic epidemiology of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 62:1997;553-561.
21. Okinaka S., Kuroiwa Y. Multiple sclerosis and allied diseases in Japan: epidemiologic and clinical aspects. Prog. Brain Res. 21:1966;183-191.
22. Kuroiwa Y., Hung T.P., Landsborough D., Park C.S., Singhal B.S. Multiple sclerosis in Asia. Neurology. 27:1977;188-192.
23. Yamasaki K., Horiuchi I., Minohara M.et al. HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain. 122:1999;1689-1696.
24. Kira J., Yamasaki K., Hoiuchi I., Ohyagi Y., Taniwaki T., Kawano Y. Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. J. Neurol. Sci. 166:1999;53-57.
25. Fukazawa T., Kikuchi S., Niino M.et al. Clinical and immunological heterogeneity in Japanese MS: distinct characteristics of MS showing acute transverse myelopathy and the optico-spinal form of MS, and heterogeneity of conventional MS. Neuroimmunology. 7:1999;181-187. (in Japanese).